Psyence Group Inc (PSYG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 8 | 98 | 92 | 53 | N/A |
| Accounts receivable | 36 | 8 | -68 | 40 | N/A |
| Accounts payable and accrued liabilities | N/A | -740 | 2,452 | 88 | N/A |
| Other Working Capital | -584 | -505 | 1,821 | 33 | 76 |
| Other Operating Activity | -5,010 | -3,778 | -7,939 | -3,773 | -123 |
| Operating Cash Flow | $-5,549 | $-4,916 | $-3,641 | $-3,560 | $-46 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -988 | -264 | -164 | N/A |
| Other Investing Activity | -2 | -2 | -166 | -147 | 0 |
| Investing Cash Flow | $-15 | $-990 | $-430 | $-311 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,438 | 3,388 | 0 | 1,273 | N/A |
| Debt Repayment | N/A | -3 | -3 | -4 | N/A |
| Common Stock Issued | N/A | 1,197 | 2,998 | 0 | N/A |
| Other Financing Activity | 11,957 | 0 | -34 | 0 | 30 |
| Financing Cash Flow | $13,394 | $4,582 | $2,960 | $1,270 | $30 |
| Beginning Cash Position | 1,059 | 2,383 | 3,495 | 6,096 | 141 |
| End Cash Position | 8,889 | 1,059 | 2,383 | 3,495 | 125 |
| Net Cash Flow | $7,830 | $-1,325 | $-1,111 | $-2,601 | $-16 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,549 | -4,916 | -3,641 | -3,560 | -46 |
| Capital Expenditure | -14 | -988 | -264 | -164 | N/A |
| Free Cash Flow | -5,563 | -5,905 | -3,905 | -3,724 | -46 |